CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...
A coalition of Florida hospitals alleged that they incurred damages from the pharmacy chains conspiring to drive up ...
CVS reverses Zepbound coverage on commercial formularies after patient backlash and a class-action lawsuit alleging ERISA violations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results